Medicare Enrolled
Dr. Craig Womeldorph, DO
Gastroenterology · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Womeldorph from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Womeldorph?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Womeldorph
Dr. Craig Womeldorph is a gastroenterology specialist in Fort Worth, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Womeldorph performed 636 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Womeldorph received a total of $7,718 from 49 pharmaceutical and/or device companies across 403 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Womeldorph is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 48% volume in TX
$7,718 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗636
Medicare services
Top 48% in TX for gastroenterology
Not available
Unique patients (not deduplicated)
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
80 | $201 | $1,067 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $58 | $148 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $115 | $332 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
61 | $77 | $847 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $87 | $217 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
45 | $49 | $680 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
30 | $42 | $151 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
25 | $72 | $518 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
24 | $65 | $206 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $42 | $100 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
18 | $197 | $1,537 |
| Radiologist review of bile duct tube placement imaging A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope. |
18 | $18 | $166 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $72 | $221 |
| Endoscopic ultrasound-guided needle biopsy A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel. |
15 | $195 | $1,110 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
15 | $43 | $1,509 |
| Endoscopic removal of esophagus, stomach, or small bowel polyps This procedure uses an endoscope and a mechanical snare to remove polyps or growths from the esophagus, stomach, or upper small bowel. |
13 | $122 | $827 |
| Endoscopic ultrasound of esophagus, stomach, or upper small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope. |
13 | $173 | $955 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
13 | $171 | $778 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
12 | $39 | $80 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
11 | $123 | $780 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $101 | $278 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,718
Total received (2018-2024)
Avg $1,103/year across 7 years
Top 26% in TX for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
403
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,391
2023
$1,816
2022
$1,728
2021
$1,059
2020
$358
2019
$1,152
2018
$216
Payments by company (2024)
ABBVIE INC.
$472
Janssen Biotech, Inc.
$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$109
Boston Scientific Corporation
$104
Takeda Pharmaceuticals U.S.A., Inc.
$82
QOL Medical, LLC
$81
Lilly USA, LLC
$63
GENZYME CORPORATION
$56
Merck Sharp & Dohme LLC
$48
Celgene Corporation
$48
AIMMUNE THERAPEUTICS, INC.
$47
IRONWOOD PHARMACEUTICALS, INC
$38
Ipsen Biopharmaceuticals, Inc
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Braintree Laboratories, Inc.
$20
EVOKE PHARMA, INC.
$19
Organon Llc
$19
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 49.7% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,018
Takeda Pharmaceuticals U.S.A., Inc.
$851
AbbVie Inc.
$790
ABBVIE INC.
$759
QOL Medical, LLC
$532
Janssen Biotech, Inc.
$474
Boston Scientific Corporation
$424
PFIZER INC.
$297
AbbVie, Inc.
$277
GENZYME CORPORATION
$205
Braintree Laboratories, Inc.
$198
Daiichi Sankyo Inc.
$195
Merck Sharp & Dohme LLC
$155
Janssen Scientific Affairs, LLC
$133
Celgene Corporation
$130
Ferring Pharmaceuticals Inc.
$113
Ironwood Pharmaceuticals, Inc
$110
Organon LLC
$84
RedHill Biopharma Inc.
$71
Ardelyx, Inc.
$64
Nestle HealthCare Nutrition Inc.
$64
Lilly USA, LLC
$63
Regeneron Healthcare Solutions, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Amgen Inc.
$48
Ethicon US, LLC
$48
AIMMUNE THERAPEUTICS, INC.
$47
INTERCEPT PHARMACEUTICALS, INC.
$46
IRONWOOD PHARMACEUTICALS, INC
$38
Alexion Pharmaceuticals, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$36
Evoke Pharma, Inc.
$31
Laborie Medical Technologies Corp.
$25
E.R. Squibb & Sons, L.L.C.
$24
Allergan Inc.
$23
Sandoz Inc.
$21
EVOKE PHARMA, INC.
$19
Organon Llc
$19
AstraZeneca Pharmaceuticals LP
$17
Phathom Pharmaceuticals, Inc.
$16
Concordia Pharmaceuticals Inc.
$16
Romark Laboratories, LC
$15
Intercept Pharmaceuticals, Inc.
$14
Shionogi Inc
$14
Celltrion USA Inc.
$13
Medtronic, Inc.
$13
Allergan, Inc.
$12
Synergy Pharmaceuticals Inc
$11
Apollo Endosurgery US Inc
$7
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Alinia · Bylvay · CAPTIVATOR COLD · CLENPIQ · CRE PRO · CREON · CYLTEZO · Compliance EndoKit · DIFICID · DONNATAL · DUPIXENT · ENTYVIO · EXALT Model D · Entyvio · GENERAL - ENDOCHOICE · GI GENIUS · GIMOTI · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · INJECTAFER · IQIRVO · LINX Reflux Management System · LINZESS · Linzess · MOTEGRITY · Movantik · NEXPLANON · OCALIVA · OMVOH · Overstitch · REBYOTA · REMICADE · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP BOWEL PREP · SUTAB · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · ULTOMIRIS · VIBERZI · VOQUEZNA · WallFlex Duodenal · XELJANZ · XIFAXAN · XIFAXANIBSD · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
103
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST F
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Womeldorph is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Womeldorph experienced with colon polyp removal with endoscopic snare?
Based on Medicare claims data, Dr. Womeldorph performed 80 colon polyp removal with endoscopic snare services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Womeldorph receive payments from pharmaceutical companies?
Yes. Dr. Womeldorph received a total of $7,718 from 49 companies across 403 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Womeldorph's costs compare to other gastroenterologists in Fort Worth?
Dr. Womeldorph's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Womeldorph) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Fort Worth
Browse gastroenterologists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in TX
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in TX
Which TX gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology